SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Cadila to set up an injectible facility at Vadodara

19 Aug 2013 Evaluate

Zydus Cadila is planning to set up an injectible facility at Vadodara at an investment of Rs 100 crore by 2015. It has already acquired the land for the same and it also aims to expand its hospital business across Gujarat in the next three years. The Ahmedabad-based company will target regulated markets like Brazil and Europe in the next turn.

Cadila Healthcare, the flagship company of Zydus Cadila Group, focuses on various areas, such as formulations (human and veterinary), new drug discovery, novel drug delivery, pharmaceutical ingredients, analytical research, phytochemistry, biotechnology, plant tissue culture, etc. 

Zydus Lifesciences Share Price

930.80 -16.30 (-1.72%)
24-Apr-2026 13:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.35
Dr. Reddys Lab 1327.00
Cipla 1301.40
Zydus Lifesciences 930.80
Lupin 2284.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×